95 related articles for article (PubMed ID: 2573210)
1. [Classification of HIV-associated acquired immunologic deficiency syndrome].
Bauer R; Schmitt A; Niedecken HW; Kreysel HW
Z Hautkr; 1989 Sep; 64(9):788, 791-4, 797. PubMed ID: 2573210
[TBL] [Abstract][Full Text] [Related]
2. [HIV infection and T-lymphocyte behavior: results of a study in Palermo].
Cangelosi C; Giardina RA; Pecoraro G; Marcianò R; Vitale MG; Gullotti A; Caronia F; Spanò C
Ann Ig; 1989; 1(1-2):45-50. PubMed ID: 2483080
[TBL] [Abstract][Full Text] [Related]
3. Plasma levels of viro-immunological markers in HIV-infected and non-infected Ethiopians: correlation with cell surface activation markers.
Messele T; Brouwer M; Girma M; Fontanet AL; Miedema F; Hamann D; Rinke de Wit TF
Clin Immunol; 2001 Feb; 98(2):212-9. PubMed ID: 11161977
[TBL] [Abstract][Full Text] [Related]
4. [Immunopathogenesis and therapeutic approaches in acquired immunologic deficiency syndrome (AIDS)].
Zielinski C
Acta Med Austriaca; 1987; 14(1):5-9. PubMed ID: 2956821
[TBL] [Abstract][Full Text] [Related]
5. [Immunodeficiency and opportunistic processes in the absence of human immunodeficiency virus infection].
Soriano V; Castro A
Med Clin (Barc); 1993 Mar; 100(9):351-5. PubMed ID: 8095996
[No Abstract] [Full Text] [Related]
6. Modelling the influence of activation-induced apoptosis of CD4+ and CD8+ T-cells on the immune system response of a HIV-infected patient.
Stan GB; Belmudes F; Fonteneau R; Zeggwagh F; Lefebvre MA; Michelet C; Ernst D
IET Syst Biol; 2008 Mar; 2(2):94-102. PubMed ID: 18397120
[TBL] [Abstract][Full Text] [Related]
7. [Effect of opportunistic infections on the frequency of leukocyte subpopulations from type-1 human immunodeficiency virus infected individuals].
Ramírez Z; Cataño JC; Román A; Rugeles MT; Montoya CJ
Biomedica; 2008 Mar; 28(1):64-77. PubMed ID: 18645662
[TBL] [Abstract][Full Text] [Related]
8. Enumeration of T-cells subsets in patients with HIV infection.
Rabson A
AIDS Clin Care; 1995 Jan; 7(1):1-3. PubMed ID: 11362161
[TBL] [Abstract][Full Text] [Related]
9. CD4+ T-cell subsets: what really counts in preventing HIV disease?
Mason RD; De Rose R; Kent SJ
Expert Rev Vaccines; 2008 Mar; 7(2):155-8. PubMed ID: 18324885
[No Abstract] [Full Text] [Related]
10. CD4 validation for the World Health Organization classification and clinical staging of HIV/AIDS in a developing country.
Edathodu J; Ali B; Alrajhi AA
Int J Infect Dis; 2009 Mar; 13(2):243-6. PubMed ID: 18945632
[TBL] [Abstract][Full Text] [Related]
11. Relationship of antibodies against CD4+ T cells in HIV-infected patients to markers of activation and progression: autoantibodies are closely associated with CD4 cell depletion.
Müller C; Kukel S; Bauer R
Immunology; 1993 Jun; 79(2):248-54. PubMed ID: 8102120
[TBL] [Abstract][Full Text] [Related]
12. [Prevalence of HIV infection and changes in CD4/CD8 ratio in asymptomatic drug addicts].
Marra R; Schifano F; Rinaldo E
G Clin Med; 1989 Feb; 70(2):105-7. PubMed ID: 2526770
[TBL] [Abstract][Full Text] [Related]
13. Anticardiolipin antibodies in HIV infection are independently associated with antibodies to the membrane proximal external region of gp41 and with cell-associated HIV DNA and immune activation.
Martinez V; Diemert MC; Braibant M; Potard V; Charuel JL; Barin F; Costagliola D; Caumes E; Clauvel JP; Autran B; Musset L;
Clin Infect Dis; 2009 Jan; 48(1):123-32. PubMed ID: 19035778
[TBL] [Abstract][Full Text] [Related]
14. Relationship of frequency of CD4+CD25+Foxp3+ regulatory T cells with disease progression in antiretroviral-naive HIV-1 infected Chinese.
Zhang Z; Jiang Y; Zhang M; Shi W; Liu J; Han X; Wang Y; Jin X; Shang H
Jpn J Infect Dis; 2008 Sep; 61(5):391-2. PubMed ID: 18806350
[TBL] [Abstract][Full Text] [Related]
15. Assessment of nutritional, clinical, and immunologic status of HIV-infected, inner-city patients with multiple risk factors.
Luder E; Godfrey E; Godbold J; Simpson DM
J Am Diet Assoc; 1995 Jun; 95(6):655-60. PubMed ID: 7759740
[TBL] [Abstract][Full Text] [Related]
16. [Acute pneumonia and cell-mediated immunity in patients with HIV infection].
Luzzati R; Cazzadori A; Malena M; Mazzi R; Danzi MC; Ciaffoni S; Concia E; Bassetti D
Minerva Med; 1993 Mar; 84(3):95-101. PubMed ID: 8492971
[TBL] [Abstract][Full Text] [Related]
17. Immunological profiles of immune restoration disease presenting as mycobacterial lymphadenitis and cryptococcal meningitis.
Tan DB; Yong YK; Tan HY; Kamarulzaman A; Tan LH; Lim A; James I; French M; Price P
HIV Med; 2008 May; 9(5):307-16. PubMed ID: 18400078
[TBL] [Abstract][Full Text] [Related]
18. [The infection and immunity of HIV: hope and thought].
Shang H
Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(4):220-2. PubMed ID: 17425861
[No Abstract] [Full Text] [Related]
19. The expansion of CD8 lymphocytes using T cell receptor variable gene products during HIV infection.
De Paoli P; Caffau C; D'Andrea M; Ceolin P; Simonelli C; Tirelli U; Santini G
Clin Exp Immunol; 1993 Dec; 94(3):486-9. PubMed ID: 7902788
[TBL] [Abstract][Full Text] [Related]
20. HIV-specific cellular immune response is inversely correlated with disease progression as defined by decline of CD4+ T cells in relation to HIV RNA load.
Oxenius A; Price DA; Hersberger M; Schlaepfer E; Weber R; Weber M; Kundig TM; Böni J; Joller H; Phillips RE; Flepp M; Opravil M; Speck RF;
J Infect Dis; 2004 Apr; 189(7):1199-208. PubMed ID: 15031788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
